Eupraxia Pharmaceuticals Shares Decline After $55 Million Equity Offering Is Priced
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) saw its shares fall about 8% on Thursday following the announcement of a priced public offering expected to raise roughly $55 million in gross proceeds. The clinical-stage company is issuing common shares and pre-funded warrants, and has granted underwriters an option to purchase additional shares. Procee…